BRCA1-associated structural variations are a consequence of polymerase theta-mediated end-joining
Cancer mutational signatures have been associated with defects in genome maintenance pathways. Here the authors, by using a worm germline mutagenesis model defective of human orthologue BRCA-1, identify polymerase theta-mediated end-joining (TMEJ) as causing the BRCAness mutational signature.
Saved in:
Main Authors: | J. A. Kamp, R. van Schendel, I. W. Dilweg, M. Tijsterman |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/7e9ffb55af7f4b2f9a5cfebaf60ef6ca |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BRCA2 antagonizes classical and alternative nonhomologous end-joining to prevent gross genomic instability
by: Jinhua Han, et al.
Published: (2017) -
Recurrent deletions in clonal hematopoiesis are driven by microhomology-mediated end joining
by: Tzah Feldman, et al.
Published: (2021) -
Genetic determinants of cellular addiction to DNA polymerase theta
by: Wanjuan Feng, et al.
Published: (2019) -
Molecular basis of microhomology-mediated end-joining by purified full-length Polθ
by: Samuel J. Black, et al.
Published: (2019) -
Clinical consequences of BRCA2 hypomorphism
by: Laia Castells-Roca, et al.
Published: (2021)